You have free access to this content

Hepatology

Cover image for Hepatology

November 2005

Volume 42, Issue 5

Pages 985–1238

  1. Hepatology Highlights

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
      Hepatology highlights (pages 985–986)

      Neil Kaplowitz

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20945

  2. Concise Review in Mechanisms of Disease

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
      Insulin resistance: A metabolic pathway to chronic liver disease (pages 987–1000)

      Elisabetta Bugianesi, Arthur J. McCullough and Giulio Marchesini

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20920

  3. Editorial

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      The CAR nuclear receptor and hepatocyte proliferation (pages 1004–1008)

      Robert H. Costa, Vladimir V. Kalinchenko, Yongjun Tan and I-Ching Wang

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20953

    3. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
      Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokinetics (pages 1010–1018)

      Regino P. González-Peralta, Deirdre A. Kelly, Barbara Haber, Jean Molleston, Karen F. Murray, Maureen M. Jonas, Mark Shelton, Giorgina Mieli-Vergani, Yoav Lurie, Steven Martin, Thomas Lang, Andrew Baczkowski, Michael Geffner, Samir Gupta and Mark Laughlin

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20884

    2. You have free access to this content
      HCV-associated B cell clonalities in the liver do not carry the t(14;18) chromosomal translocation (pages 1019–1027)

      Domenico Sansonno, Felicia Anna Tucci, Valli De Re, Gianfranco Lauletta, Michele Montrone, Massimo Libra and Franco Dammacco

      Version of Record online: 17 OCT 2005 | DOI: 10.1002/hep.20887

    3. You have free access to this content
      Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity (pages 1028–1036)

      Eirini I. Rigopoulou, Deepak Suri, Shilpa Chokshi, Ivana Mullerova, Steven Rice, Richard S. Tedder, Roger Williams and Nikolai V. Naoumov

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20888

    4. You have free access to this content
      Mannose-binding lectin in chronic hepatitis B virus infection (pages 1037–1045)

      Wai Po Chong, Yuk Fai To, Wai Kee Ip, Man Fung Yuen, Tung Ping Poon, Wilfred H.S. Wong, Ching Lung Lai and Yu Lung Lau

      Version of Record online: 17 OCT 2005 | DOI: 10.1002/hep.20891

    5. You have free access to this content
      Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus (pages 1046–1054)

      Masataka Tsuge, Nobuhiko Hiraga, Hideki Takaishi, Chiemi Noguchi, Hiromi Oga, Michio Imamura, Shoichi Takahashi, Eiji Iwao, Yoshifumi Fujimoto, Hidenori Ochi, Kazuaki Chayama, Chise Tateno and Katsutoshi Yoshizato

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20892

    6. You have free access to this content
      Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity (pages 1055–1062)

      Darren J. Schofield, Birke Bartosch, Yohko K. Shimizu, Tobias Allander, Harvey J. Alter, Suzanne U. Emerson, François-Loïc Cosset and Robert H. Purcell

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20906

  5. Liver Biology and Pathobiology

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
      Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice (pages 1063–1071)

      Patrick Bertolino, Arnhild Schrage, David G. Bowen, Katja Klugewitz, Saeed Ghani, Katharina Eulenburg, Lauren Holz, Nancy Hogg, Geoffrey W. McCaughan and Alf Hamann

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20885

    2. You have free access to this content
      Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat (pages 1072–1081)

      Daniel Benten, Vinay Kumaran, Brigid Joseph, Jörn Schattenberg, Yury Popov, Detlef Schuppan and Sanjeev Gupta

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20889

    3. You have free access to this content
      Lack of gp130 expression results in more bacterial infection and higher mortality during chronic cholestasis in mice (pages 1082–1090)

      Torsten Wuestefeld, Christian Klein, Konrad L. Streetz, Naiara Beraza, Jürgen Schölmerich, Lawrence J. Burgart, Lars Zender, Stefan Kubicka, Gregory J. Gores, Michael P. Manns and Christian Trautwein

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20912

    4. You have free access to this content
      Altered disposition of acetaminophen in mice with a disruption of the Mrp3 gene (pages 1091–1098)

      José E. Manautou, Dirk R. de Waart, Cindy Kunne, Noam Zelcer, Michael Goedken, Piet Borst and Ronald Oude Elferink

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20898

    5. You have free access to this content
      Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice (pages 1099–1108)

      Hongtao Wang, Bhupinder P.S. Vohra, Yan Zhang and Robert O. Heuckeroth

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20903

    6. You have free access to this content
      Ethanol metabolism alters interferon gamma signaling in recombinant HepG2 cells (pages 1109–1117)

      Natalia A. Osna, Dahn L. Clemens and Terrence M. Donohue Jr.

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20909

    7. You have free access to this content
      Gadd45β is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia (pages 1118–1126)

      Amedeo Columbano, Giovanna M. Ledda-Columbano, Monica Pibiri, Costanza Cossu, Marta Menegazzi, David D. Moore, Wendong Huang, Jianmin Tian and Joseph Locker

      Version of Record online: 17 OCT 2005 | DOI: 10.1002/hep.20883

    8. You have free access to this content
      Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma (pages 1127–1136)

      Meta W. Djojosubroto, Allison C. Chin, Ning Go, Sonja Schaetzlein, Michael P. Manns, Sergei Gryaznov, Calvin B. Harley and K. Lenhard Rudolph

      Version of Record online: 19 AUG 2005 | DOI: 10.1002/hep.20822

    9. You have free access to this content
      Temporal correlation of pathology and DNA damage with gene expression in a choline-deficient model of rat liver injury (pages 1137–1147)

      Christine L. Powell, Oksana Kosyk, Blair U. Bradford, Joel S. Parker, Edward K. Lobenhofer, Ayumi Denda, Fumiyuki Uematsu, Dai Nakae and Ivan Rusyn

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20910

    10. You have free access to this content
      A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-κB inhibitor, IκBα (pages 1148–1157)

      Robert A. DeAngelis, Maciej M. Markiewski, Rebecca Taub and John D. Lambris

      Version of Record online: 17 OCT 2005 | DOI: 10.1002/hep.20879

  6. Liver Failure and Liver Disease

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
      High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study (pages 1158–1165)

      Oliviero Riggio, Cesare Efrati, Carlo Catalano, Federica Pediconi, Oriano Mecarelli, Neri Accornero, Francesca Nicolao, Stefania Angeloni, Andrea Masini, Lorenzo Ridola, Adolfo F. Attili and Manuela Merli

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20905

    2. You have free access to this content
      Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients (pages 1166–1174)

      Erwin Geuken, Dorien S. Visser, Henri G.D. Leuvenink, Koert P. de Jong, Paul M.J.G. Peeters, Maarten J.H. Slooff, Folkert Kuipers and Robert J. Porte

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20886

    3. You have free access to this content
      Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease (pages 1175–1183)

      Giovanni Musso, Roberto Gambino, Marilena Durazzo, Giampaolo Biroli, Monica Carello, Emanuela Fagà, Giovanni Pacini, Franco De Michieli, Laura Rabbione, Alberto Premoli, Maurizio Cassader and Gianfranco Pagano

      Version of Record online: 17 OCT 2005 | DOI: 10.1002/hep.20896

    4. You have free access to this content
      Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis (pages 1184–1193)

      Burton Combes, Scott S. Emerson, Nancy L. Flye, Santiago J. Munoz, Velimir A. Luketic, Marlyn J. Mayo, Timothy M. McCashland, Rowen K. Zetterman, Marion G. Peters, Adrian M. Di Bisceglie, Kent G. Benner, Kris V. Kowdley, Robert L. Carithers Jr., Leonard Rosoff Jr., Guadalupe Garcia-Tsao, James L. Boyer, Thomas D. Boyer, Enrique J. Martinez, Nathan M. Bass, John R. Lake, David S. Barnes, Maurizio Bonacini, Karen L. Lindsay, A. Scott Mills, Rodney S. Markin, Raphael Rubin, A. Brian West, Donald E. Wheeler, Melissa J. Contos and Alan F. Hofmann

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20897

    5. You have free access to this content
      Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients (pages 1194–1202)

      M. Eric Gershwin, Carlo Selmi, Howard J. Worman, Ellen B. Gold, Mitchell Watnik, Jessica Utts, Keith D. Lindor, Marshall M. Kaplan and John M. Vierling

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20907

  7. Hepatology Elsewhere

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
    2. You have free access to this content
  8. AASLD Practice Guideline

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
      Management of hepatocellular carcinoma (pages 1208–1236)

      Jordi Bruix and Morris Sherman

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20933

  9. Correspondence

    1. Top of page
    2. Hepatology Highlights
    3. Concise Review in Mechanisms of Disease
    4. Editorial
    5. Viral Hepatitis
    6. Liver Biology and Pathobiology
    7. Liver Failure and Liver Disease
    8. Hepatology Elsewhere
    9. AASLD Practice Guideline
    10. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Reply (pages 1237–1238)

      Jordan Feld and E. Jenny Heathcote

      Version of Record online: 25 OCT 2005 | DOI: 10.1002/hep.20954

SEARCH

SEARCH BY CITATION